Metabolic syndrome in Internal Medicine patients: the pilot NIMEC study (National Internal Medicine Equivalent/Complex C-V-@Risk)

BACKGROUND Metabolic Syndrome (MetS), currently defined as slight differences in the criteria of diagnosis – depending on which authority is quoted [i.e.: NCEP-ATP III (National Cholesterol Education Program/Adult Treatment Panel III); WHO (World Health Organization); IDF (International Diabetes Fed...

Full description

Bibliographic Details
Main Authors: R. Nardi, I. Blasi, R. Alduino, S. Arnone, A. Sferrazza, S. La Carrubba, I. Iori, S. Di Rosa, G. Scanelli, for the NIMEC Investigators Group, S. Corrao
Format: Article
Language:English
Published: PAGEPress Publications 2013-05-01
Series:Italian Journal of Medicine
Subjects:
Online Access:http://www.italjmed.org/index.php/ijm/article/view/345
_version_ 1797429288912289792
author R. Nardi
I. Blasi
R. Alduino
S. Arnone
A. Sferrazza
S. La Carrubba
I. Iori
S. Di Rosa
G. Scanelli
for the NIMEC Investigators Group
S. Corrao
author_facet R. Nardi
I. Blasi
R. Alduino
S. Arnone
A. Sferrazza
S. La Carrubba
I. Iori
S. Di Rosa
G. Scanelli
for the NIMEC Investigators Group
S. Corrao
author_sort R. Nardi
collection DOAJ
description BACKGROUND Metabolic Syndrome (MetS), currently defined as slight differences in the criteria of diagnosis – depending on which authority is quoted [i.e.: NCEP-ATP III (National Cholesterol Education Program/Adult Treatment Panel III); WHO (World Health Organization); IDF (International Diabetes Federation); AACE (American Association of Clinical Endocrinologists)], designates a cluster of metabolic risk factors that come together in a single individual, leading to cardiovascular disease. MetS is quite common, approximately 20-30% of the population in industrialized countries being affected. However, most of epidemiological data regarding MetS are derived from populations consisting mostly of middle-aged and younger subjects. <br />AIM OF THE STUDY To assess the prevalence of the MetS in Internal Medicine wards and to determine its related comorbidities, including other clinical forms of atherosclerotic disease such as CHD risk equivalents. METHODS Our study was performed in patients admitted in Internal Medicine wards and selected as a randomization list in 12 Emilia Romagna-Marche FADOI centers. 1.316 patients were registered. According to explicit inclusion/exclusion criteria, we studied overall 902 participants (50.6% men, mean of age: 71-73 years). <br />RESULTS According to NCEP-ATP III and IDF criteria the prevalence of MetS was 45.3% (IC 95%: 41.6-49.1) and 38.6% (IC 95%: 34.9-42.3), respectively. Patients with MetS presented a higher significant rate of ALT increase, syncope, atrial fibrillation, COPD, unstable angina, chronic kidney disease, cancer, valvular heart disease, peripheral arterial disease and carotid plaques. A strong association between IDF-MetS and congestive heart failure was observed, suggesting a role of central obesity as an independent risk factor in the elderly. <br />DISCUSSION World-wide populations are becoming older. Aging and MetS are two conditions that represent an important part of health-care spending. Trunkal fatness increases in old age, potentially increasing existing abdominal fatness prevalent during middle age which is already related to increased size, cardiovascular disease and the metabolic syndrome. In this study we sought to assess the high impact of MetS in Internal Medicine wards, confirming its significant relationships to many comorbidities among older adults. <br />CONCLUSIONS Our study emphasizes the importance of MetS and related diseases, pointing out the emerging problem of its real impact on management of these complex patients. Further research is needed to define the optimal body composition for older adults and to identify interventions that reduce morbidity and healthcare costs of MetS for this age group.
first_indexed 2024-03-09T09:11:01Z
format Article
id doaj.art-7669d1acbda344bf8cec73c2de8ea16e
institution Directory Open Access Journal
issn 1877-9344
1877-9352
language English
last_indexed 2024-03-09T09:11:01Z
publishDate 2013-05-01
publisher PAGEPress Publications
record_format Article
series Italian Journal of Medicine
spelling doaj.art-7669d1acbda344bf8cec73c2de8ea16e2023-12-02T08:35:37ZengPAGEPress PublicationsItalian Journal of Medicine1877-93441877-93522013-05-0113213110.4081/itjm.2007.3.21299Metabolic syndrome in Internal Medicine patients: the pilot NIMEC study (National Internal Medicine Equivalent/Complex C-V-@Risk)R. NardiI. BlasiR. AlduinoS. ArnoneA. SferrazzaS. La CarrubbaI. IoriS. Di RosaG. Scanellifor the NIMEC Investigators GroupS. CorraoBACKGROUND Metabolic Syndrome (MetS), currently defined as slight differences in the criteria of diagnosis – depending on which authority is quoted [i.e.: NCEP-ATP III (National Cholesterol Education Program/Adult Treatment Panel III); WHO (World Health Organization); IDF (International Diabetes Federation); AACE (American Association of Clinical Endocrinologists)], designates a cluster of metabolic risk factors that come together in a single individual, leading to cardiovascular disease. MetS is quite common, approximately 20-30% of the population in industrialized countries being affected. However, most of epidemiological data regarding MetS are derived from populations consisting mostly of middle-aged and younger subjects. <br />AIM OF THE STUDY To assess the prevalence of the MetS in Internal Medicine wards and to determine its related comorbidities, including other clinical forms of atherosclerotic disease such as CHD risk equivalents. METHODS Our study was performed in patients admitted in Internal Medicine wards and selected as a randomization list in 12 Emilia Romagna-Marche FADOI centers. 1.316 patients were registered. According to explicit inclusion/exclusion criteria, we studied overall 902 participants (50.6% men, mean of age: 71-73 years). <br />RESULTS According to NCEP-ATP III and IDF criteria the prevalence of MetS was 45.3% (IC 95%: 41.6-49.1) and 38.6% (IC 95%: 34.9-42.3), respectively. Patients with MetS presented a higher significant rate of ALT increase, syncope, atrial fibrillation, COPD, unstable angina, chronic kidney disease, cancer, valvular heart disease, peripheral arterial disease and carotid plaques. A strong association between IDF-MetS and congestive heart failure was observed, suggesting a role of central obesity as an independent risk factor in the elderly. <br />DISCUSSION World-wide populations are becoming older. Aging and MetS are two conditions that represent an important part of health-care spending. Trunkal fatness increases in old age, potentially increasing existing abdominal fatness prevalent during middle age which is already related to increased size, cardiovascular disease and the metabolic syndrome. In this study we sought to assess the high impact of MetS in Internal Medicine wards, confirming its significant relationships to many comorbidities among older adults. <br />CONCLUSIONS Our study emphasizes the importance of MetS and related diseases, pointing out the emerging problem of its real impact on management of these complex patients. Further research is needed to define the optimal body composition for older adults and to identify interventions that reduce morbidity and healthcare costs of MetS for this age group.http://www.italjmed.org/index.php/ijm/article/view/345Abdominal obesityMetabolic syndromeOverweight in older persons.
spellingShingle R. Nardi
I. Blasi
R. Alduino
S. Arnone
A. Sferrazza
S. La Carrubba
I. Iori
S. Di Rosa
G. Scanelli
for the NIMEC Investigators Group
S. Corrao
Metabolic syndrome in Internal Medicine patients: the pilot NIMEC study (National Internal Medicine Equivalent/Complex C-V-@Risk)
Italian Journal of Medicine
Abdominal obesity
Metabolic syndrome
Overweight in older persons.
title Metabolic syndrome in Internal Medicine patients: the pilot NIMEC study (National Internal Medicine Equivalent/Complex C-V-@Risk)
title_full Metabolic syndrome in Internal Medicine patients: the pilot NIMEC study (National Internal Medicine Equivalent/Complex C-V-@Risk)
title_fullStr Metabolic syndrome in Internal Medicine patients: the pilot NIMEC study (National Internal Medicine Equivalent/Complex C-V-@Risk)
title_full_unstemmed Metabolic syndrome in Internal Medicine patients: the pilot NIMEC study (National Internal Medicine Equivalent/Complex C-V-@Risk)
title_short Metabolic syndrome in Internal Medicine patients: the pilot NIMEC study (National Internal Medicine Equivalent/Complex C-V-@Risk)
title_sort metabolic syndrome in internal medicine patients the pilot nimec study national internal medicine equivalent complex c v risk
topic Abdominal obesity
Metabolic syndrome
Overweight in older persons.
url http://www.italjmed.org/index.php/ijm/article/view/345
work_keys_str_mv AT rnardi metabolicsyndromeininternalmedicinepatientsthepilotnimecstudynationalinternalmedicineequivalentcomplexcvrisk
AT iblasi metabolicsyndromeininternalmedicinepatientsthepilotnimecstudynationalinternalmedicineequivalentcomplexcvrisk
AT ralduino metabolicsyndromeininternalmedicinepatientsthepilotnimecstudynationalinternalmedicineequivalentcomplexcvrisk
AT sarnone metabolicsyndromeininternalmedicinepatientsthepilotnimecstudynationalinternalmedicineequivalentcomplexcvrisk
AT asferrazza metabolicsyndromeininternalmedicinepatientsthepilotnimecstudynationalinternalmedicineequivalentcomplexcvrisk
AT slacarrubba metabolicsyndromeininternalmedicinepatientsthepilotnimecstudynationalinternalmedicineequivalentcomplexcvrisk
AT iiori metabolicsyndromeininternalmedicinepatientsthepilotnimecstudynationalinternalmedicineequivalentcomplexcvrisk
AT sdirosa metabolicsyndromeininternalmedicinepatientsthepilotnimecstudynationalinternalmedicineequivalentcomplexcvrisk
AT gscanelli metabolicsyndromeininternalmedicinepatientsthepilotnimecstudynationalinternalmedicineequivalentcomplexcvrisk
AT forthenimecinvestigatorsgroup metabolicsyndromeininternalmedicinepatientsthepilotnimecstudynationalinternalmedicineequivalentcomplexcvrisk
AT scorrao metabolicsyndromeininternalmedicinepatientsthepilotnimecstudynationalinternalmedicineequivalentcomplexcvrisk